⌘K

Home/Filings/4/A/0001209191-19-023074

4/A//SEC Filing

Ettenberg Seth 4/A

Accession 0001209191-19-023074

CIK 0001622229other

View on SEC.gov Company Profile

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 4:13 PM ET

Size

6.1 KB

Accession

0001209191-19-023074

Insider Transaction Report

Form 4/AAmended

Period: 2019-03-25

Unum Therapeutics Inc.UMRX

Chief Scientific Officer

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2019-03-25−11,485→ 329,145 total
Exercise: $0.18Exp: 2025-01-28→ Common Stock (11,485 underlying)

Footnotes (1)

[F1]25% of the shares vests on September 3, 2015, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Persons continuous service with the Issuer.

Documents

1 file

4
doc4a.xml
FORM 4/A SUBMISSION

Issuer

Unum Therapeutics Inc.

CIK 0001622229

Entity typeother

Related Parties

1

filerCIK 0001734419

Filing Metadata

Form type: 4/A
Filed: Apr 2, 8:00 PM ET
Accepted: Apr 3, 4:13 PM ET
Size: 6.1 KB

View on SEC.gov